Tender Details

Country: Germany
Summary: Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for the Active Ingredients Evolocumab and Eslicarbazepine
DET Ref No: 49404107
Deadline: 10 Jan 2023
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: 1.00
Notice Type: Tender
Document Ref. No.: 027141-2021
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Document Type: Contract notice
Title: Conclusion of non-exclusive discount agreements in accordance with Section 130a, Paragraph 8 of Book V of the Social Code (SGB V) for the active ingredients evolocumab and eslicarbazepine
Reference Number: 2021 / S 013-027141
Contract Type: Supplies
Estimated Value: 1.00 - EUR
Description: Section 130a, Paragraph 8 of Book V of the Social Code enables the health insurances (KK) and pharmaceutical companies to conclude framework discount agreements on the drugs to be dispensed at the expense of the statutory KK. GWQ acts as a company for efficiency and quality at KK in accordance with Section 130a, Paragraph 8, Sentence 5 of the Social Security Code (SGBV) for its shareholder and customer accounts. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB takes place by GWQ ServicePlus AG. Until new drug discount agreements come into effect, GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies as part of the open-house procedure for preparations with the active ingredients evolocumab and eslicarbazepine. The earliest contract start is March 1st, 2021.

336 ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for the Active Ingredients Evolocumab and Eslicarbazepine - Germany Tender

The GWQ SERVICEPLUS AG, a Government sector organization in Germany, has announced a new tender for Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for the Active Ingredients Evolocumab and Eslicarbazepine. This tender is published on GermanyTenders under DET Ref No: 49404107 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-01-10.

The estimated tender value is 1.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.